Search the MBS

Ureteroscopy, of one ureter, with or without any one or more of, cystoscopy, ureteric meatotomy or ureteric dilatation, plus destruction of stone in the ureter with ultrasound, electrohydraulic or kinetic lithotripsy, or laser, with or without extraction of fragments, not being a service associated with a service to which item 36803 or 36812 applies, or a service associated with a service to which item 36806, 36824 or 36848 applies to a procedure performed on the same ureter

Multiple Operation Rule

Fee: $917.00 Benefit: 75% = $687.75

• Previous - Item 36806
• Next - Item 36811

Prostate or prostatic bed, needle biopsy of, by the transrectal route, using prostatic ultrasound guidance and obtaining one or more prostatic specimens, being a service associated with a service to which item 55603 applies

Multiple Operation Rule

Fee: $154.60 Benefit: 75% = $115.95 85% = $131.45

(See para TN.8.160 of explanatory notes to this Category)

• Previous - Item 37215
• Next - Item 37217

Prostate, implantation of radio-opaque fiducial markers into the prostate gland or prostate surgical bed, under ultrasound guidance, being an item associated with a service to which item 55603 applies

Multiple Operation Rule

Fee: $152.20 Benefit: 75% = $114.15 85% = $129.40

(See para TN.8.54 of explanatory notes to this Category)

• Previous - Item 37216
• Next - Item 37218

Prostate or prostatic bed, needle biopsy of, by the transperineal route, using prostatic ultrasound guidance and obtaining one or more prostatic specimens, being a service associated with a service to which item 55600 or 55603 applies

Multiple Operation Rule

Fee: $371.05 Benefit: 75% = $278.30 85% = $315.40

(See para TN.8.160 of explanatory notes to this Category)

• Previous - Item 37218
• Next - Item 37220

Prostate, radioactive seed implantation of, urological component, using transrectal ultrasound guidance:

(a) for a patient with:

(i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and

(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and

(iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and

(b) performed by a urologist at an approved site in association with a radiation oncologist; and

(c) being a service associated with:

(i) services to which items 15338 and 55603 apply; and

(ii) a service to which item 60506 or 60509 applies

Multiple Operation Rule

Fee: $1,149.35 Benefit: 75% = $862.05

(See para TN.8.55 of explanatory notes to this Category)

• Previous - Item 37219
• Next - Item 37221

PROSTATIC COIL, insertion of, under ultrasound control

Multiple Operation Rule

Fee: $227.05 Benefit: 75% = $170.30

• Previous - Item 37221
• Next - Item 37224

PROSTATE, transperineal insertion of catheters into, for high dose rate brachytherapy using ultrasound guidance including any associated cystoscopy. The procedure must be performed at an approved site in association with a radiation oncologist, and be associated with a service to which item 15331 or 15332 applies.

Multiple Operation Rule

Fee: $622.80 Benefit: 75% = $467.10 85% = $529.40

(See para TN.8.56 of explanatory notes to this Category)

• Previous - Item 37226
• Next - Item 37245

Penis, correction of chordee with incision or excision of fibrous plaque or plaques, with or without mobilisation of one or both of the neuro-vascular bundle and urethra

Multiple Operation Rule

Fee: $816.15 Benefit: 75% = $612.15 85% = $717.45

• Previous - Item 37417
• Next - Item 37423

Use of a coronary pressure wire, if the service is:

(a) performed during selective coronary angiography, percutaneous angioplasty or transluminal insertion of one or more stents; and

(b) to measure fractional flow reserve, non-hyperaemic pressure ratios or coronary flow reserve in intermediate coronary artery or graft lesions (stenosis of 50 to 70%); and

(c) to determine whether revascularisation is appropriate, if previous functional imaging:

(i) has not been performed; or

(ii) has been performed but the results are inconclusive or do not apply to the vessel being interrogated; and

(d) performed on one or more coronary vascular territories

Multiple Operation Rule

Fee: $516.90 Benefit: 75% = $387.70 85% = $439.40

• Previous - Item 38213
• Next - Item 38244

Transcatheter occlusion of left atrial appendage, and cardiac catheterisation performed by the same practitioner, for stroke prevention in a patient who has non‑valvular atrial fibrillation, if:

(a) the patient is at increased risk of thromboembolism demonstrated by:

(i) a prior stroke (whether of an ischaemic or unknown type), transient ischaemic attack or non‑central nervous system systemic embolism; or

(ii) at least 2 of the following risk factors:

(A) an age of 65 years or more;

(B) hypertension;

(C) diabetes mellitus;

(D) heart failure or left ventricular ejection fraction of 35% or less (or both);

(E) vascular disease (prior myocardial infarction, peripheral artery disease or aortic plaque); and

(b) the patient has an absolute and permanent contraindication to oral anticoagulation (confirmed by written documentation that is provided by a medical practitioner, independent of the practitioner rendering the service); and

(c) the service is not associated with a service to which item 38200, 38203, 38206 or 38254 applies

(H) 

Multiple Operation Rule

Fee: $1,004.15 Benefit: 75% = $753.15

(See para TN.8.132 of explanatory notes to this Category)

• Previous - Item 38275
• Next - Item 38285